According to the international consensus statement on antiphospholipid syndrome (APS), aPL of IgA isotype (either anticardiolipin antibodies [aCL] or anti-β2-glycoprotein I antibodies [anti-β2GPI]) do not fulfill laboratory criteria for APS classification [1]. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.